Qube Research & Technologies LTD Jazz Pharmaceuticals PLC Transaction History

Qube Research & Technologies LTD

$65.7 Billion
Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 99,351 shares of JAZZ stock, worth $12 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

99,351

Previous 5,700 1643.0%

Holding current value

$12 Million

Previous $608,000 1721.22%

% of portfolio

0.02%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.57 - $116.37 $9.42 Million - $10.9 Million	93,651 Added 1643.0%	99,351 $11.1 Million
Q2 2024 Aug 14, 2024	SELL	$103.94 - $118.98 $7.57 Million - $8.66 Million	-72,801 Reduced 92.74%	5,700 $608,000
Q1 2024 May 14, 2024	SELL	$115.19 - $132.77 $33.3 Million - $38.4 Million	-289,234 Reduced 78.65%	78,501 $9.45 Million
Q4 2023 Feb 13, 2024	BUY	$114.26 - $136.0 $8.7 Million - $10.4 Million	76,157 Added 26.12%	367,735 $45.2 Million
Q3 2023 Nov 13, 2023	SELL	$122.0 - $145.31 $11.9 Million - $14.1 Million	-97,299 Reduced 25.02%	291,578 $37.7 Million
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $35.1 Million - $42.2 Million	286,600 Added 280.22%	388,877 $48.2 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $4.01 Million - $4.81 Million	29,958 Added 41.42%	102,277 $15 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $3.11 Million - $3.84 Million	-24,005 Reduced 24.92%	72,319 $11.5 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $12.2 Million - $15.5 Million	96,324 New	96,324 $12.8 Million
Q1 2022 May 09, 2022	SELL	$129.64 - $160.7 $3.77 Million - $4.67 Million	-29,072 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$119.87 - $145.67 $3.48 Million - $4.23 Million	29,072 New	29,072 $3.7 Million
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $640,369 - $919,884	-4,978 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$160.2 - $186.42 $4.78 Million - $5.56 Million	-29,821 Reduced 85.69%	4,978 $884,000
Q1 2021 May 14, 2021	BUY	$150.19 - $173.5 $5.23 Million - $6.04 Million	34,799 New	34,799 $5.72 Million
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $1.17 Million - $1.6 Million	-11,071 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$95.68 - $121.88 $32,244 - $41,073	-337 Reduced 2.95%	11,071 $1.22 Million
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $880,207 - $1.53 Million	-10,032 Reduced 46.79%	11,408 $1.14 Million
Q4 2019 Feb 13, 2020	BUY	$117.65 - $153.73 $2.52 Million - $3.3 Million	21,440 New	21,440 $3.2 Million
Q4 2018 Feb 14, 2019	SELL	$115.94 - $166.74 $11,594 - $16,674	-100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $16,101 - $18,057	100 New	100 $17,000

Others Institutions Holding JAZZ

# of Institutions

511

Shares Held

57.6M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.57B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Jazz Pharmaceuticals PLC Transaction History